Changchun Genescience Pharmaceutical Co., Ltd.

This early-stage study tests a new drug, GenSci139, in 280 adults with advanced solid tumors that have spread. The goal is to find a safe dose and see if it can shrink tumors. The study is currently recruiting.

This early-stage study tests a single injection of a new drug called GenSci098 in 24 adults with Graves' disease, a condition where the thyroid is overactive. The main goal is to check if the drug is safe and how well people tolerate it. Researchers will monitor participants for …

This early-stage study tests a new drug called GenSci140 in people with advanced solid tumors, including ovarian cancer. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 170 participants will be enrolled in China.

This study looks at how well a drug called nanocrystalline megestrol acetate works for cancer patients who have cachexia, a condition causing severe weight loss and poor appetite. About 495 adults with cancer will take the drug, and researchers will check if their appetite and we…

This early-stage study tests whether a new drug called GenSci136 is safe in healthy adults. About 48 people in China will receive a single injection of either the drug or a placebo. The main goal is to check for side effects, not to treat any disease.